Mascoma Wealth Management’s Merrimack Pharmaceuticals, Inc. MACK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-5,000
| Closed | -$61.7K | – | 514 |
|
|
2023
Q3 | $61.7K | Hold |
5,000
| – | – | 0.02% | 166 |
|
|
2023
Q2 | $61.1K | Hold |
5,000
| – | – | 0.02% | 176 |
|
|
2023
Q1 | $62.1K | Hold |
5,000
| – | – | 0.02% | 214 |
|
|
2022
Q4 | $57.3K | Hold |
5,000
| – | – | 0.02% | 214 |
|
|
2022
Q3 | $19K | Hold |
5,000
| – | – | 0.01% | 334 |
|
|
2022
Q2 | $30K | Hold |
5,000
| – | – | 0.01% | 303 |
|
|
2022
Q1 | $32K | Hold |
5,000
| – | – | 0.01% | 323 |
|
|
2021
Q4 | $20K | Hold |
5,000
| – | – | 0.01% | 334 |
|
|
2021
Q3 | $24K | Buy |
+5,000
| New | +$24K | 0.01% | 277 |
|
|
2021
Q2 | – | Sell |
-5,000
| Closed | -$31K | – | 472 |
|
|
2021
Q1 | $31K | Buy |
+5,000
| New | +$31K | 0.01% | 259 |
|
|
2017
Q3 | – | Sell |
-127
| Closed | -$1K | – | 430 |
|
|
2017
Q2 | $1K | Buy |
+127
| New | +$1K | ﹤0.01% | 401 |
|